PubChem's BioAssay Database by Wang, Yanli et al.
PubChem’s BioAssay Database
Yanli Wang*, Jewen Xiao, Tugba O. Suzek, Jian Zhang, Jiyao Wang, Zhigang Zhou,
Lianyi Han, Karen Karapetyan, Svetlana Dracheva, Benjamin A. Shoemaker,
Evan Bolton, Asta Gindulyte and Stephen H. Bryant*
National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health,
Bethesda, MD, 20894, USA
Received September 9, 2011; Revised November 7, 2011; Accepted November 8, 2011
ABSTRACT
PubChem (http://pubchem.ncbi.nlm.nih.gov) is a
public repository for biological activity data of
small molecules and RNAi reagents. The mission
of PubChem is to deliver free and easy access to
all deposited data, and to provide intuitive data
analysis tools. The PubChem BioAssay database
currently contains 500000 descriptions of assay
protocols, covering 5000 protein targets, 30000
gene targets and providing over 130 million bioactiv-
ity outcomes. PubChem’s bioassay data are
integrated into the NCBI Entrez information retrieval
system, thus making PubChem data searchable and
accessible by Entrez queries. Also, as a repository,
PubChem constantly optimizes and develops its de-
position system answering many demands of both
high- and low-volume depositors. The PubChem in-
formation platform allows users to search, review
and download bioassay description and data. The
PubChem platform also enables researchers to
collect, compare and analyze biological test
results through web-based and programmatic
tools. In this work, we provide an update for the
PubChem BioAssay resource, including information
content growth, data model extension and new de-
velopments of data submission, retrieval, analysis
and download tools.
INTRODUCTION
PubChem (1–3) (http://pubchem.ncbi.nlm.nih.gov) is a
public information resource for archiving chemical struc-
tures and biological properties of small molecules and
siRNA reagents. It is hosted by the National Center for
Biotechnology Information (NCBI) (4), a division of the
National Library of Medicine under the National
Institutes of Health since 2004. The PubChem BioAssay
database currently consists of bioactivity information
generated by high-throughput screenings and medicinal
chemistry studies. In addition, the PubChem BioAssay
database contains a few dozen high-throughput RNAi
screens against complete genomes. These data are
integrated with the rest of the NCBI resources, making
PubChem a widely used public information system for
chemical biology and drug discovery research.
The PubChem BioAssay database is organized as a set
of relational databases deployed on Microsoft SQL
servers. The infrastructure allows for seamlessly storing
the submitted bioassay records, tracking and versioning
subsequent updates, and supporting data retrieval and
analysis. PubChem provides a user-friendly deposition
system to facilitate data exchanges and submissions. To
make the vast bioactivity information easily accessible to
the scientiﬁc community, PubChem provides a suite of
integrated services enabling users to analyze biological
test results, identify and validate drug targets and
evaluate chemical and RNAi probes. To meet the
increasing demand from public users and from rapid
growth of data volume and complexity, PubChem main-
tains and develops its service to the community as a public
data repository by optimizing and expanding its bioassay
data model for supporting broader types of information,
by developing infrastructure to ensure database scalabil-
ity, by improving deposition system to ease information
exchange, and by enhancing search, retrieval, analysis and
download tools. In this work, we will provide brief de-
scriptions of these important components of the
PubChem BioAssay resource with an emphasis on the
new developments within each section.
BioAssay DATA CONTENT
The PubChem BioAssay database currently contains
500000 bioassay records, a total of over 130000000
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These test results represent rich biological properties for
120 chemical probes, 1600000 small molecules and 60000
RNAi reagents. They also provide unique annotations for
over 5000 protein targets tested in small molecule
screenings and 30000 gene targets tested by RNAi
screenings. This information is contributed by over 40
organizations including US government agencies,
NIH-funded screening centers, pharmaceutical companies
and worldwide research laboratories. A summary of
bioassay depositions is available at http://pubchem.ncbi
.nlm.nih.gov/sources#assay.
PubChem continues to host screening data generated by
the NIH Molecular Libraries and Imaging Program
(MLP) (http://commonfund.nih.gov/molecularlibraries/).
Contributions from some other organizations were
described previously (1). In the past 2 years, PubChem
has additionally received bioassay depositions from or-
ganizations with large-scale screening facilities and indi-
vidual research groups. For example, researchers at
UCLA deposited their research data from a study on the
survival of human embryonic stem cells with a chemical
genomics approach (5). The ICCB-Longwood/NSRB
Screening Facility at the Harvard Medical School
(http://iccb.med.harvard.edu/) contributed a number of
high-throughput screening data sets containing inhibition
activity of small molecules for several biologically import-
ant targets. The Drosophila RNAi Screening Center
(DRSC) (6) has recently submitted a number of data
sets with RNA interference screening results against the
Drosophila genome. As an endeavor to ﬁght malarial
disease (7) and share the scientiﬁc discovery with the
worldwide community, Glaxo Smith Kline teamed up
with public domain data providers and deposited the anti-
malarial data sets into PubChem (http://www.prnewswire
.com/news-releases/gsk-and-online-communities-create-
unique-alliance-to-stimulate-open-source-drug-discovery-
for-malaria-94430694.html). This exemplary model was
followed by scientists at Abbot Labs: two data sets of
bioassay data reporting collective information on a
drug–target network study were submitted to PubChem
(8). In addition, a cell viability assay and a caspase 3/7
assay were deposited by the Laboratory of Environmental
Genomics at the Carolina Center for Computational toxi-
cology, University of North Carolina at Chapel Hill
(http://comptox.unc.edu/); and a USP14 inhibitor assay
was deposited by the Finley and King Labs at the
Harvard Medical School (9). Following the deposition
of the siRNA circadian assay (http://pubchem.ncbi.nlm.
nih.gov/assay/assay.cgi?aid=1904) contributed by collab-
orators, the Kay laboratory at the University of California
at San Diego contributed two small molecule screening
data sets to PubChem (10,11). These three data sets on
circadian research are linked to each other in PubChem as
related bioassays speciﬁed by depositors. This linkage
makes an excellent showcase to demonstrate that RNAi
screenings complement small molecule assays as they can
be joined together to explore the key genes and proteins
critical to the circadian pathway. Most of these depos-
itions have accompanying results published in scientiﬁc
journals, thereby giving PubChem a valuable role as
a hub linking raw and annotated scientiﬁc data with
their respective research papers.
PubChem collaborates with the European
Bioinformatics Institute (EBI) and mirrors the full
ChEMBL database (12). This data set covers over 30000
publications from 17 scientiﬁc journals. PubChem assigns
a unique PubChem BioAssay accession (AID) to each of
the imported bioassay records, and provides cross-links to
the respective ChEMBL web pages. Protein type targets
with high annotation conﬁdence from ChEMBL are
recorded in PubChem as bioassay targets after mapping
to GenBank records, while those with lower conﬁdence
are recorded as descriptive comments. PubChem ﬂags
the endpoints in ChEMBL, such as IC50, EC50, Ki,
with the ‘active concentration’ attribute, and converts
readout values to uM (micromolar) units in compliance
with the PubChem data standard. This allows PubChem
to link each ChEMBL assay to a subset of compounds
with potency of  1uM and  1nM, respectively. For
ChEMBL bioassay records that are derived from the
same research article, PubChem tracks their inherited
relationship and marks these assays as same-publication-
based related bioassays, which could be useful from
a research point of view. For additional context,
PubChem retrieves from PubMed the title and abstract
of the publication associated with a ChEMBL bioassay,
presents them in the PubChem bioassay summary page
and indexes them in Entrez to facilitate database search.
PubChem further integrates ChEMBL data to the rest
data content in PubChem with a set of data analysis
tools enabling researchers to compare recently generated
HTS data to research results reported in the literature to
accelerate discovery process.
PubChem BioAssay STANDARD AND DATA
MODEL
PubChem is aimed to accommodate diverse bioactivity
information with a ﬂexible BioAssay data model and
database schema, and continues to expand the types of
data it accepts as experimental methodologies evolve.
The data model (1) was designed to unambiguously rep-
resent bioassay protocols, molecule target information,
other cross-database references, bioactivity summary
results and user-deﬁned readout types associated with
tested reagents. A depositor is able to provide as many
detailed test results as needed for delivering the research
ﬁndings. As a result, one can report replications of a
speciﬁc readout as well as one or multiple series of dose–
response data points. The PubChem bioactivity summary
result, e.g. bioactivity outcome, score and active concen-
tration attribute, allows one to rank and evaluate the hits
identiﬁed in the screening experiment. It supports
cross-links from the bioassay record to chemical probes,
bioactive compounds, as well as a subset of compounds
with certain potency. Moreover, it allows PubChem to
provide tools to enable in-depth data analysis and com-
parison across multiple bioassay results.
PubChem provides several schemes for depositors to
report targets for tested reagents. The ‘classical’ model for
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the entire set of small molecule compounds. The ‘panel’
model reports multiple bioactivity outcomes against differ-
ent targets as well as multiple cell lines or species. It can also
be used to report results from multiple but highly related
experiments. Through this model, depositor may designate
the respective targets to a group of test results (TID), for
example. Another model is to accommodate screening re-
sults of different types of test reagents, such as RNAi probe
molecules. In this case, each tested RNAi reagent aims for
its own target. Thus, a depositor can specify the gene target
for each reagent and provide this information under a gene
target column in the test result data table. Similarly,
PubChem now allows other types of cross-reference, such
as those to PubMed, GenBank or NCBI Probe databases,
to be speciﬁed per each tested substance.
In addition to the bioassay relationship annotation
provided by depositors, PubChem provides several com-
putational methods to associate bioassays, resulting in
several kinds of related bioassays based on target
sequence similarity, common active compounds,
common biological pathways as well as data abstracted
from the same publication. As a result, RNAi screenings
in PubChem are automatically linked to small molecule
assays if the biologically responsive genes from an RNAi
screening and the protein targets of small molecules are
involved in the same pathway.
PubChem allows depositors to provide updates to their
records. The nature of bioassay update could vary from
ﬁxing a simple typo to providing additional descriptive
information, cross references, or test results. As an im-
portant aspect of a public archival system, the PubChem
BioAssay data model and database schema are carefully
designed with infrastructure for supporting, tracking and
storing updates and modiﬁcations to the existing bioassay
records. By default, PubChem shows and distributes the
information from the most recent version of a bioassay
record through its web services and FTP sites; however,
earlier versions of the record can be retrieved through the
BioAssay Summary web service upon user request.
Depositors may provide cross-references in their sub-
missions to link the bioassay record to taxonomy, gene
or 3D structure of the target. A new ﬁeld recently added
to the PubChem BioAssay data model allows one to
highlight primary citations out of a list of PubMed
cross-references. PubMed citations designated as primary
should reference papers containing experimental informa-
tion directly relevant to the bioassay record, thus helping
PubChem users better understand the assay results.
Reciprocally, such PubChem/PubMed direct links will
also allow PubMed users to immediately access assay
results, hence facilitating information integration by
PubChem and other NCBI resources.
PubChem provides a generic bioassay data model to
capture common elements essential for recording
screening results. With the increasing growth in data di-
versity and request for recording information relevant to a
speciﬁc project, a new data ﬁeld, e.g. ‘categorized
comment’, has recently been introduced, which allows de-
positors to provide information categories and textual
data associated with each category. This mechanism
offers the means and ﬂexibility for depositors to provide
the information pertinent to a focused research area, to
comply with recommendations on data standard from a
working group or to meet the guidelines of data exchange
and sharing as required by a research community or con-
sortium. This mechanism makes it easier for depositors to
validate information prior to submission, and enables
them to adequately describe projects for internal require-
ments. Meanwhile, such a semi-structured data model
allows PubChem to accommodate a greater diversity of
information content critical to multiple research
communities. It also allows PubChem to tailor its tools
to search, present and classify the information in the
future. An example of a bioassay containing categorized
comments is available at http://pubchem.ncbi.nlm.nih
.gov/assay/assay.cgi?aid=540333.
All information from a BioAssay deposition can be
wrapped up as an XML or ASN.1 data object. A
complete list of data ﬁelds for the PubChem BioAssay
data model, and detailed descriptions of their usage, can
be obtained by following the XML schema or equivalent
ASN.1 speciﬁcation at the PubChem FTP web sites:
ftp://ftp.ncbi.nlm.nih.gov/pubchem/speciﬁcations/
pubchem.xsd
ftp://ftp.ncbi.nlm.nih.gov/pubchem/speciﬁcations/
pubchem.asn
PUBLIC ACCESS AND SEARCH
An individual record in the PubChem BioAssay database
can be accessed directly through the BioAssay Summary
service at http://pubchem.ncbi.nlm.nih.gov/assay/assay.
cgi?aid=myAID, where ‘myAID’ is a valid numeric
PubChem BioAssay accession (AID). This service
provides access to all versions of deposited assay informa-
tion, such as assay protocol, test result descriptions and
data (Figure 1). It allows one to retrieve, view, and
download test results through the ‘Show Data’ links.
The service also lists information about the assay target,
including depositor-provided molecular information and
annotations derived by PubChem about protein family
classiﬁcation, the corresponding gene, pathway and hom-
ologous 3D structures. Furthermore, the BioAssay
Summary service provides a central entry point to a set
of data analysis tools for the bioactive compounds
identiﬁed in the assay. These analysis tools can be
accessed through the ‘BioActivity Summary’, ‘Structure–
Activity Analysis’ and ‘Structure Clustering’ links, and
allow one to cluster the scaffolds of the tested compounds,
examine and visualize SAR relationships, and evaluate
target speciﬁcity or promiscuity properties of the com-
pounds. In addition, the ‘Related BioAssays’ section lists
assays that may be related to the one under review and
links to further detailed summary over the bioassay rela-
tionship. Cross-references to other NCBI databases, such
as PubMed, are listed under the ‘Links’ section.
PubChem BioAssay records can be searched in the
NCBI information retrieval system Entrez. Descriptive in-
formation content in the BioAssay database is indexed
D402 Nucleic AcidsResearch, 2012, Vol.40,Database issueunder multiple ﬁelds to facilitate general as well as speciﬁc
searches for bioassay records. A full list of indexed ﬁelds
and ﬁlters, such as assay name, description, protocol,
target description, readout name and tested chemical
name, are documented at the PubChem Help page
(http://pubchem.ncbi.nlm.nih.gov/help.
html#PubChemindex). Entrez BioAssay search can be
accessed at http://www.ncbi.nlm.nih.gov/pcassay/ or at
http://pubchem.ncbi.nlm.nih.gov. Documentation for
general use of the NCBI Entrez system is available at
http://www.ncbi.nlm.nih.gov/Database/index.html.
Detailed description for making an effective Entrez
bioassay query has been described previously (1,3) and
will be further described below.
The Entrez system allows users to perform a search with
a single keyword, or a complex query against one or
Figure 1. The summary view of a PubChem bioassay record. Assay results can be retrieved through the Show Data j Active and Show Data j All
links.
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http://www.ncbi.nlm.nih.gov/pcassay?term=gleevec to
ﬁnd out assays containing the text word ‘gleevec’ in any
part of the bioassay records. One can further limit the
search to a speciﬁc data ﬁeld, for example, to
use http://www.ncbi.nlm.nih.gov/pcassay?term=gleevec
[SynonymTested] to ﬁnd out assays where the compound
gleevec is tested, and use http://www.ncbi.nlm.nih
.gov/pcassay?term=gleevec[SynonymTested] AND geﬁti
nib[SynonymTested] to retrieve assays which tested both
gleevec and geﬁtinib. For speciﬁc searches, one may use
the Entrez ‘Limits’ page at http://www.ncbi.nlm.nih.gov/
pcassay/limits. Users can pick a search ﬁeld given in the
‘Search Field Tags’ section or build up a complex query
using other input boxes on the page. One can further join
the results from multiple searches using the ‘Search
History’ features accessible from the ‘Advanced’ page at
http://www.ncbi.nlm.nih.gov/pcassay/advanced.
In addition to indexing data submitted by depositor,
PubChem also indexes data derived by PubChem, thus
making bioassay data records more discoverable. One of
the derived indexes is the gene name corresponded to the
protein target, which includes ofﬁcial symbol and gene
synonyms provided in the NCBI Gene database. Search
through gene symbol name of the bioassay target can be
advantageous as it may bring up assays which contain
variations of protein target names and molecular identi-
ﬁers. For example, one can collect over 600 assays target-
ing on human ERG following the query http://www.ncbi
.nlm.nih.gov/pcassay?term=KCNH2[genesymbol],
among which users can ﬁnd a bioassay deposited by
PDSP, a dozen hERG inhibitor screening assays from
the Johns Hopkins Ion Channel Center, and several
hundred bioassay records from ChEMBL. These
bioassay depositions provide protein target references to
a list of different protein records in Entrez Protein
database. However, despite differences in protein identi-
ﬁers, these records contain identical protein sequence in-
formation and point to the same gene record in the NCBI
Gene database; hence, a larger set of bioassay records can
be identiﬁed with a single query by gene name rather than
by protein name or molecular identiﬁer.
As the majority of bioassay records in PubChem are
associated with publications, PubChem now indexes
journal name and publication date for all cross-references
to PubMed. Thus, one can search bioassays by limiting
the query to the ‘JournalName’ ﬁeld. One can also use
the ‘Cited Publication’ menu on the Limits page
to search assays associated with a selected journal.
PubChem extended Entrez’s ‘auto-complete’ feature
to the BioAssay database which covers several index
ﬁelds including ‘JournalName’, ‘ProteinTargetName’,
‘TaxonomyName’ and data ‘SourceName’. This fea-
ture can be accessed on the ‘Advanced’ page, where select-
ing the ‘JournalName’ ﬁeld and entering ‘med’ in the
‘Search Builder’ input box will bring up a list of journal
names including ‘Journal of Medicinal Chemistry’,
‘European Journal of Medicinal Chemistry’ etc., for
example.
Entrez presentation (e.g. DocSum report) for the
PubChem BioAssay database has recently been converted
to a display style generic to all Entrez databases
(Figure 2). The DocSum report links to the full
summary of a bioassay record through the bioassay title,
and connects to the bioassay data table through the
‘All data’ or ‘Active data’ link. One can also access in-
formation related to a bioassay record following the
‘Protein Target’, ‘Compounds, Active’, ‘PubMed
Citation’ links. New features have been developed for
the BioAssay DocSum report to allow one to easily
reﬁne the search results and subsequently focus on
a subset of assays of interest. BioAssay records among
the search results are grouped and summarized
under the ‘Reﬁne your results’ section based on bioassay
target, bioactivity potency, experiment type and depositor
category. Using that interface, users can narrow down to
a subset of assays targeting on a speciﬁc protein, or
assays containing inhibitors of  1uM (or  1nM, not
shown in Figure 2) potency. Furthermore, users can now
download selected bioassay records using the ‘BioAssay
Download’ function given in the ‘Actions on your results’
section. The ‘Find related data’ feature links to the
cross-references among the resulted records to other
NCBI databases.
BioActivity ANALYSIS TOOLS
PubChem provides web-based and programmatic tools for
users to retrieve, analyze and export bioactivity data in the
BioAssay database. A list of web-based bioactivity
analysis tools and their URLs are summarized in
Table 1, which can also be accessed from the PubChem
web page at http://pubchem.ncbi.nlm.nih.gov/assay.
These tools allow users to retrieve assay descriptions and
data, review related bioassays, compare bioactivity data
from multiple experiments and explore structure–activity
relationship. Some of these tools have been described in
detail previously (2). Enhancements for the data analysis
tools and new services developed in the past 2 years are
summarized below.
Compound-centric and target-centric BioActivity
Summary tools
The BioActivity Summary service is a central tool for
summarizing available bioactivity information for one or
a set of compounds, bioassays and targets. The assay-
centric view (Figure 3A) of this service presents the bio-
activity data from the assay point of view as previously
described (2). Two new components, e.g. compound-
centric view and target-centric view, have been added to
this service. The compound-centric page provides an
overview of the bioactivity data available from the
compound point of view. It summarizes the bioassay ex-
periments and protein targets for each compound and
groups such information based on bioactivity outcome
and potency range (Figure 3B). Each summary count
shown in the table also represents a link which, if
followed, leads to detailed bioactivity results for the
compound and the associated assays/targets. Most of the
high-throughput screen data sets in PubChem contain bio-
activity outcome speciﬁcation, e.g. active versus inactive.
D404 Nucleic AcidsResearch, 2012, Vol.40,Database issueOn the other hand, the majority of the assays mirrored
from ChEMBL do not contain such explicit bioactivity
annotation, but many contain potency speciﬁcity.
Therefore, users are highly recommended to follow up
with results linked under both the bioactivity outcomes
and potency (e.g. Active Concentrations) columns. The
target-centric page (Figure 3C) provides a summary for
the assay experiments associated with a protein target.
More importantly, it highlights the compounds exhibiting
desired bioactivity for the given target. This service
provides users with a path to narrow down chemical
modulators with certain potency and follow up with the
assay experiments; thus, it can turn into an annotation
service for protein and genes. These tools may prove
useful for users to explore the biological processes in
which a small molecule is involved, or search the
chemical modulations of a biological pathway.
Enhanced assay-centric BioActivity Summary tool
As compounds in PubChem are often tested in hundreds
or even thousands of bioassays, retrieving data from
database and generating a summary view can be time
consuming, thus requests to the BioActivity Summary
service are put into a queue system. On the other hand,
the assay-centric service has recently been improved. It
now promptly returns a summary of bioactivity
outcome, potency, assay and target information for
a single SID or CID input. With this enhancement on
data retrieval and presentation, this new tool allows one
to quickly gather and export ﬁrst-hand bioactivity infor-
mation for a particular compound. One can also
bookmark the URL to monitor new discoveries on a
known drug or a small molecule of interest.
Dose–response curve drawing tool
Conﬁrmatory assays in PubChem often contain one or
multiple series of dose-response data. These assays can
be searched using the interface provided on the Entrez
PubChem BioAssay ‘Limits’ page or directly following
the URL at http://www.ncbi.nlm.nih.gov/pcassay?term=
doseresponse[ﬁlt]. To facilitate the assessment of dose–
response relationship and better evaluate the potency
and efﬁcacy of a tested compound, PubChem now
provides a new service to calculate and draw a ﬁtted
dose–response curve. In this service, the dose–response
data are ﬁtted with the Hill equation based on a nonlinear
regression algorithm developed by Pinto et al.( 13). One
can visualize the ﬁtted dose–response curve by clicking on
the dose–response icon contained in the assay data
table view of a conﬁrmatory assay, or pick an assay ac-
cession (AID) and a substance accession (SID) using the
web interface at http://pubchem.ncbi.nlm.nih.gov/
assay/plot.cgi?plottype=1 (Figure 4).
Figure 2. Entrez DocSum report for bioassay search results.
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D406 Nucleic AcidsResearch, 2012, Vol.40,Database issueFigure 3. PubChem BioActivity Summary service. (A) assay-centric view for multiple compounds; (B) compound-centric view; (C) target-centric
view; (D) assay centric view for a single compound.
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PubChem provides multiple services for users to
download bioassay records or summarized bioactivity in-
formation. Most of the bioactivity analysis services
described in this work or previously (2) offer download
functionality. Assay descriptions and data table can also
be retrieved and downloaded through a programmatic
interface using the PubChem PUG/SOAP facilities
(http://pubchem.ncbi.nlm.nih.gov/pug/pughelp.html). In
this work, we focus on describing two major BioAssay
download services: enhanced FTP and a new web service.
BioAssay FTP
PubChem BioAssay FTP (ftp://ftp.ncbi.nlm.nih.gov/
pubchem/Bioassay) provides open access to deposited
bioassay records. PubChem updates the BioAssay FTP
site daily in incremental mode with new and modiﬁed bio-
assay records. One can check the time stamp for the new
deposition or update, and check the nature and history of
an update by referring to the ‘assay.ftpdump.history’ ﬁle
at the FTP site. In addition to depositor-provided
bioassay records, annotations derived by PubChem on
bioassay relationships can also be downloaded at ftp://
ftp.ncbi.nlm.nih.gov/pubchem/Bioassay/AssayNeighbors/.
PubChem allows one to download bioassay records in
ASN, XML and ‘comma-separated values’ (CSV)
formats. The structure of the FTP site is organized accord-
ing to the respective data formats as shown in Figure 5,
e.g. ASN and XML sub-directories provide bioassay
records containing both assay description and data in
ASN.1 and XML format, respectively. The CSV
sub-directory provides CSV-formatted assay data and
XML-formatted assay description. The Concise directory
contains the XML/ASN/CSV sub-directories with the
same structure, but provides only summary assay results
including bioactivity outcome, score and active concentra-
tion. Due to the large number of bioassay records, bulk
downloads from the FTP site are now assisted by the
‘zip’ compression of multiple records per ﬁle with
BioAssay AID ranges in the ﬁlenames, such as
‘0000001_0001000.zip’.
Figure 4. A new service for drawing dose–response curves.
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PubChem now provides a web-based interactive Bioassay
Download service (Figure 6) to support on-demand bulk
download of selected bioassay records. This new web
interface can be accessed by following the download
icon on a BioAssay Entrez DocSum page (Figure 2)
to export records identiﬁes based on a user’s search
criteria. It can also be accessed directly at http://
pubchem.ncbi.nlm.nih.gov/assay/assaydownload.cgi. It
allows one to provide a list of AID and retrieve bioassay
data and descriptions for up to 1000 bioassay records at a
time. One can compose such an AID list by putting
together the accessions of assays from a speciﬁc data
source, or from related assay targets, for example.
Moreover, one can also provide a list of PubChem
Substance IDs (SIDs) as additional input and request a
subset of assay results associated with the speciﬁed sub-
stances, thus making it straightforward to carry out appli-
cations, such as to collect bioactivity data for a group of
related chemical structures.
BioAssay DEPOSITION SYSTEM AND UPDATE
The PubChem Deposition Gateway supports chemical
and assay data submission through a web-based system
at http://pubchem.ncbi.nlm.nih.gov/deposit/. The depos-
ition system also allows bulk data upload via private
FTP accounts. A non-trivial task for the system is to
validate the submitted data content and provide ﬂexible
interface for editing the submissions. Tracking frequent
updates to deposited bioassay records represents another
challenge as depositors may add additional test results
or provide a complete replacement for the entire assay
data set.
There is a great variation in complexity of bioassay de-
positions ranging from very large primary screens with
simple endpoints to assays containing dose–response
data points or even multiple bioactivity outcomes.
Accordingly, the deposition system has been further de-
veloped and allows the submission of such information for
all types of screening data. The new functionalities include
an interface to support the submission of panel assays and
categorized comments for organization-speciﬁc informa-
tion. In addition, the user interface of the deposition
system is further tailored to better support the submission
and the representation of features unique to RNAi data.
Figure 6. Web-based assay download service.
Figure 5. PubChem BioAssay FTP directory structure.
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user-deﬁned data columns to expedite the association of
gene, nucleotide, literature or other bulk annotation for
better reporting and annotating experimental results.
Procedures for validating submitted cross-references
have also been optimized recently.
Supporting simultaneous submission of such diverse set
of data types and sizes from multiple depositors requires
interface ﬂexibility and multi-thread processing infrastruc-
ture. Many automated (and in some cases manual) checks
of incoming data are required to ensure conformity to
data speciﬁcations and an efﬁcient reporting system is
needed for communicating problems within the submitted
data to depositors. A number of additional enhancements
have been made to the PubChem deposition system to ease
and accelerate data submissions. Some of these new add-
itions and improvements to this process are described in
this work.
New format for submitting substance records
The PubChem Deposition Gateway now accepts sub-
stance submission in CSV format and via web form
input. A bioassay test result is always linked to a sub-
stance with a unique PubChem substance accession
(SID), making it necessary for depositors to submit sub-
stance record prior to bioassay data. The majority of sub-
stance records in PubChem are small molecules, which
have been deposited in the chemistry-standard SDF ﬁle
format. However, PubChem also accepts non-small
molecule substances, in particular, RNAi reagents for
submitting RNAi screening results into the BioAssay
database.
To ease the submission of substance records for general
biologists, substance records can now be uploaded as a
standard spreadsheet ﬁle, including CSV, or ﬁles sup-
ported by Excel or OpenOfﬁce. Through the use of
PubChem headers in the spreadsheet ﬁle, attributes for
RNAi reagents can be speciﬁed, e.g., cross-references to
gene targets, nucleotides and taxonomy records. Small
molecule information including structures can also be
added to a spreadsheet by using SMILES, synonyms,
URLs, external identiﬁers etc. In addition, a third
option for submitting chemical structure is now available
via a web form allowing depositors to draw a structure or
to generate it from an identiﬁer. Help document is avail-
able at http://pubchem.ncbi.nlm.nih.gov/deposit/deposit_
help.html#ﬁle.
New method for submitting bioassay description
Due to the inherent complexity of bioassay data, support
of the deposition system is a demanding task. The depos-
ition system provides a ﬂexible web interface guiding a
depositor to enter the assay description information via
web forms (or optionally by XML upload) and subse-
quently upload the assay data table in a CSV format.
In addition, one can provide assay description and data
in a single XML ﬁle via a private FTP account. This
method continues to be the most ﬂexible way for an insti-
tution to automate the upload of large amounts of data.
However, for more occasional users or for those looking
for better integration with experimental data ﬁles, the
simpler spreadsheet format well used by biologists needs
to be supported by the deposition system.
A spreadsheet ﬁle (CSV, or ﬁles supported by Excel and
OpenOfﬁce programs) can now be used to fully deﬁne a
bioassay description. The hierarchical structure of assay
description supported by the PubChem BioAssay data
model is organized into six groups of information,
including general assay descriptions, result deﬁnitions,
target deﬁnitions, external references, categorized
comments and panel assay information. The information
in each group can be represented with one spreadsheet. In
the panel spreadsheet ﬁle, each row represents a panel
member, and data on the columns provide detailed infor-
mation for the respective panel member. Details about the
format, header standards and accepted data types
required for each description group are provided at
http://pubchem.ncbi.nlm.nih.gov/deposit/docs/assay_desc
ription_csv_tags.html. This new method allows depositors
to package the entire deﬁnition of the assay into a single
Excel or OpenOfﬁce ﬁle containing several spreadsheets
for each logical section of the assay description. Help
documentation for this new assay submission method is
available at http://pubchem.ncbi.nlm.nih.gov/deposit/
deposit_help.html#assay_descr.ssheetload.
Fast Preview System for quick feedback
An important step for depositing data into PubChem is
the ability for depositors to review the content and the
presentation of their submission before releasing the
data. A ‘Preview’ facility is provided for both substance
and assay depositions. It closely imitates the presentation
of the data content in the publication format and can be
accessed by depositor for verifying their data integrity and
that everything submitted appears as expected. Due to the
complexity of bioassay data ﬁelds and the corresponding
data storage infrastructure, display assay ‘preview’ was
only available for depositors after a few hours delay. A
new dataﬂow and storage scheme has been developed to
eliminate the turn-around time and bioassay ‘preview’
interface is now generated instantly. Multiple preview/
update cycles are often required to identify and ﬁx
problems before committing the data for publication in
PubChem. With this enhancement for the preview
facility, depositor can now get instant feedback about
their submission through the fast preview page, hence,
to address problems without delay. This new feature
greatly improves the deposition workﬂow and allows de-
positors to complete the bioassay submission and review
the presentation of the data set in PubChem within a few
minutes.
Stable account ID and ability to change display Data
Source
A technical improvement has been made to deposition
account management: establishment of stable Data
Source Identiﬁer and modiﬁable Data Source Name
(DSN). The former can be thought of as an ‘account
ID’ for each data source which remains unchanged for
the life of the account. This stability persists across
Nucleic Acids Research, 2012,Vol.40, Database issue D411personnel changes and is essential for an archiving
database like PubChem. The DSN, on the other hand,
may be changed by depositors to allow them to adjust
their source name attribute visible to the outside world.
This change may become necessary when, for example,
depositing institution’s name changes or the main depos-
ition account holder moves to a different university, etc.
As a result, a deposition account ID may be associated
with multiple DSN. Tracking source names and source
identiﬁers is very important for PubChem as they can be
used as terms in generating Entrez queries.
SUMMARY
PubChem is set up to serve as a public repository for bio-
activity data of small molecules and RNAi. An integrated
information platform is provided at PubChem with a suite
of tools allowing users to query PubChem databases and
analyze the retrieved substance records and bioactivity
data. PubChem will continue to improve the existing
tools and develop new services to optimize the utility of
bioactivity data contained in the BioAssay database.
Further integration with Entrez system will provide anno-
tation services for genomic resources by linking to small
molecule modulators or effective RNAi reagents as
identiﬁed by screening experiments. A number of new
features and data exchange methods have been added to
the PubChem Deposition Gateway in the past 2 years to
ease and simplify data submission process. An actively
undergoing project is to provide a ‘lite’ version of the
PubChem Deposition Gateway with the goal to provide
one-time depositors a quick one-step service. PubChem
welcomes the community to utilize the resource, provide
feedback, and to contribute data content to the repository.
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